Advertisement
ResearchIn-Press PreviewAgingNeuroscience
Open Access |
10.1172/JCI207965
1Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2Helexva Inc., Pittsburgh, United States of America
Find articles by
Jauhari, A.
in:
PubMed
|
Google Scholar
|
1Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2Helexva Inc., Pittsburgh, United States of America
Find articles by
Baranov, S.
in:
PubMed
|
Google Scholar
|
1Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2Helexva Inc., Pittsburgh, United States of America
Find articles by Monek, A. in: PubMed | Google Scholar
1Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2Helexva Inc., Pittsburgh, United States of America
Find articles by Singh, T. in: PubMed | Google Scholar
1Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2Helexva Inc., Pittsburgh, United States of America
Find articles by Li, F. in: PubMed | Google Scholar
1Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2Helexva Inc., Pittsburgh, United States of America
Find articles by Pickford, M. in: PubMed | Google Scholar
1Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2Helexva Inc., Pittsburgh, United States of America
Find articles by Suofu, Y. in: PubMed | Google Scholar
1Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2Helexva Inc., Pittsburgh, United States of America
Find articles by
Carlisle, D.
in:
PubMed
|
Google Scholar
|
1Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2Helexva Inc., Pittsburgh, United States of America
Find articles by Friedlander, R. in: PubMed | Google Scholar
Published November 19, 2026 - More info
Mitochondrial failure is a convergent driver of neuronal aging and neurodegeneration, yet upstream factors that link age-associated changes to mitochondrial homeostasis remain incompletely defined. Melatonin, which is synthesized within neuronal mitochondria, declines with age and is further exacerbated in several neurodegenerative disorders. Here we show that endogenous melatonin is required to maintain cerebral mitochondrial biogenesis and mitochondrial quality through the SIRT1/PGC-1α signaling axis. Across young (8-week), adult (20-week), and middle-aged (1-year) mouse brains, aging was associated with reduced SIRT1/PGC-1α, decreased mtDNA copy number, and diminished abundance of oxidative phosphorylation proteins. Human hippocampal samples from older donors similarly exhibited reduced SIRT1/PGC-1α but retained mitochondrial protein abundance while accumulating oxidatively damaged mitochondria and showing reduced LC3B, consistent with impaired mitochondrial quality control. In aralkylamine N-acetyltransferase knockout (AANAT-KO) mice, endogenous melatonin deficiency suppressed SIRT1/PGC-1α, NRF1, and TFAM in an age-dependent manner, reduced mtDNA and mitochondrial transcript abundance, lowered mitochondrial protein levels, and increased mitochondrial oxidative damage. Melatonin supplementation restored the biogenesis program, increased mtDNA and mitochondrial transcripts, and rescued respiratory chain protein abundance. Finally, mitochondrial transplantation experiments indicated that mitochondrial quality contributes to neuronal integrity. Melatonin-deficient mitochondria induced neurite degeneration in wild-type neurons, whereas wild-type mitochondria rescued neurite architecture and improved survival in melatonin-deficient neurons. Together, these findings identify endogenous melatonin as a regulator of cerebral mitochondrial biogenesis and suggest that melatonin decline contributes to mitochondrial-mediated neuritic degeneration and neuronal loss.